These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10141085)

  • 1. Warnings for health care products: a communication perspective.
    Mundt J; Driver RW
    Health Mark Q; 1994; 12(2):55-75. PubMed ID: 10141085
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 3. Unknown safety profile of ingredients in hair supplements: A call to action for improved patient safety.
    Pathoulas JT; Bellefeuille G; Lofgreen SJ; Shaik J; Hordinsky MK; Sadick NS; Farah RS
    J Am Acad Dermatol; 2020 Sep; 83(3):e213-e214. PubMed ID: 32417421
    [No Abstract]   [Full Text] [Related]  

  • 4. The end of paternalism: a new approach to food labeling.
    Steinborn SB; Todd KA
    Food Drug Law J; 1999; 54(3):401-22. PubMed ID: 11797706
    [No Abstract]   [Full Text] [Related]  

  • 5. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1995 Jan; 273(4):279. PubMed ID: 7815644
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of labeling of foods and pharmaceuticals.
    Viscusi WK
    Annu Rev Public Health; 1994; 15():325-43. PubMed ID: 8054088
    [No Abstract]   [Full Text] [Related]  

  • 7. Off-label uses of drugs and medical devices: should the FDA crack down?
    Margolis RE
    Healthspan; 1993 Jan; 10(1):18-9. PubMed ID: 10124289
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk communication for labeling all ingredients in consumer products.
    Lee BM; Choi M; Shin I; Kim J; Choi Z; Kim K; Choi K; Yang S; So DY; Tae Ju S; Kwon S
    J Toxicol Environ Health A; 2020 Jul; 83(13-14):509-524. PubMed ID: 32552538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European GMO labeling thresholds impractical and unscientific.
    Weighardt F
    Nat Biotechnol; 2006 Jan; 24(1):23-5. PubMed ID: 16404384
    [No Abstract]   [Full Text] [Related]  

  • 10. Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
    Soller RW; Rice LG; Ambrose PJ
    Food Drug Law J; 2007; 62(2):375-86. PubMed ID: 17632967
    [No Abstract]   [Full Text] [Related]  

  • 11. Marketing health care products on the Internet: a proposal for updated federal regulations.
    Green K
    Am J Law Med; 1998; 24(2-3):365-86. PubMed ID: 9702278
    [No Abstract]   [Full Text] [Related]  

  • 12. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GMOs, genetically modified organisms or genuinely mixed opinions? A reasonable Consumer’s understanding of the terms "GMO" and "non-GMO," and the struggle to set a Standard. .
    Kromka NJ
    Seton Hall Law Rev; 2017; 48(1):221-48. PubMed ID: 29236423
    [No Abstract]   [Full Text] [Related]  

  • 14. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for tuning GMO detection in seed and grain.
    Macarthur R; Murray AW; Allnutt TR; Deppe C; Hird HJ; Kerins GM; Blackburn J; Brown J; Stones R; Hugo S
    Nat Biotechnol; 2007 Feb; 25(2):169-70. PubMed ID: 17287745
    [No Abstract]   [Full Text] [Related]  

  • 16. Prohibited acts and enforcement tools.
    Mathewson NW
    Food Drug Law J; 2010; 65(3):545-54. PubMed ID: 24479241
    [No Abstract]   [Full Text] [Related]  

  • 17. Do Consumers Want More Nutritional and Health Information on Wine Labels? Insights from the EU and USA.
    Annunziata A; Pomarici E; Vecchio R; Mariani A
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27399767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The issue of extralabel drug use.
    Kennedy JA
    J Am Vet Med Assoc; 1997 Dec; 211(11):1354. PubMed ID: 9394877
    [No Abstract]   [Full Text] [Related]  

  • 19. Obesity--the new frontier of public health law.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2006 Jun; 354(24):2601-10. PubMed ID: 16775242
    [No Abstract]   [Full Text] [Related]  

  • 20. Sidney Wolfe. Interview by Randall Osborne.
    Wolfe S
    Nat Biotechnol; 2008 Feb; 26(2):149. PubMed ID: 18259161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.